At least 28% of women will have 1 to 2 UTIs in their lifetime and 25% will have 3 or more. There are new international guidelines.
Dr. Moldwin discussed how to treat a female patient with re-current infection. Dr. Liao pointed out that currently is takes 2 to 3 days to get the result of a urine culture, but future technology will allow the urologist to make a molecular diagnosis in less than one hour and it will be done in the office. He noted that currently, there is an overuse of broad spectrum antibiotics but the future will include a patient-specific selection of antibiotics. Currently it is difficult to determine a simple versus a complicated UTI but in the future, quantitative measurement of host immunity response will be available. He discussed the use of “biosensors” which are used for glucose monitoring His laboratory is working on technology that will use a biosensor that will perform office-based urine culture testing.
Dr. Kraus then went on to discuss how to treat the patient who has a neurogenic bladder, performs IC and develops a UTI.
Reference:
Gupta, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011. 52(5):e103-20.
Panelists:Stephen Kraus (Recurrent UTIs in Neurogenic Bladder patients), Joseph Liao (What’s New in the Diagnosis of UTIs), and Robert Moldwin (Modern Strategies for Prevention of Recurrent UTIs)
Moderated by Toby Chai at the American Urological Association (AUA) Annual Meeting - May 14 - 19, 2011 - Walter E. Washington Convention Center, Washington, DC USA
Reported for UroToday by Diane K. Newman, RNC, MSN, CRNP, FAAN and Continence Nurse Practitioner Specialist - University of Pennsylvania Medical Center.
View Full AUA 2011 Meeting Coverage
